FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Analyst Earnings Estimates
TSX:FRX - Toronto Stock Exchange - CA31447P1009 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 1.54M | 21.252M 1,280.00% | 57.471M 170.43% | 61.319M 6.70% | 100.08M 63.21% | 123.21M 23.11% | 127.08M 3.14% | 172.76M 35.95% | 175.69M 1.70% | 181.53M 3.32% | 183.14M 0.89% | |
| EBITDA YoY % growth | N/A | N/A | N/A | 7.14M 216.67% | 14.688M 105.71% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.22M 3.75% | -22.59M -31.18% | -12.771M 43.47% | 592.875K 104.64% | 6.069M 923.66% | 43.226M 612.24% | 65.863M 52.37% | 63.038M -4.29% | 105.91M 68.01% | 108.84M 2.77% | 119.18M 9.50% | 127.68M 7.13% | |
| Operating Margin | N/A | -1,466.88% | -60.09% | 1.03% | 9.90% | 43.19% | 53.46% | 49.60% | 61.30% | 61.95% | 65.65% | 69.72% | |
| EPS YoY % growth | -0.67 12.99% | -0.90 -34.33% | -0.61 32.22% | 0.23 137.46% | 0.17 -24.11% | 1.46 743.14% | 1.83 25.23% | 2.13 16.16% | 3.40 59.95% | 3.47 1.95% | 3.68 6.03% | 3.84 4.44% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.17 269.32% | -0.12 -124.96% | -0.07 63.41% | 0.15 171.64% | 0.13 -24.70% |
| Revenue Q2Q % growth | 17.051M 75.15% | 8.737M -65.57% | 10.226M 40.82% | 17.231M 147.07% | 16.96M -0.53% |
| EBITDA Q2Q % growth | 510K | -204K -150.00% | 714K 75.00% | 11.322M 5,650.00% | 2.754M 440.00% |
| EBIT Q2Q % growth | -2.979M -63.84% | -1.495M -110.88% | -404.43K 91.97% | 5.427M 204.33% | 1.723M 157.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.21 -200.00% | -0.09 | -0.12 | -128.76% |
| Q2 2024 Q2Q % growth | -0.20 4.76% | -0.03 | -0.17 | -539.32% |
| Q1 2024 Q2Q % growth | 0.47 304.35% | 0.27 | 0.20 | 75.87% |
| Q4 2023 Q2Q % growth | -0.10 61.54% | -0.02 | -0.08 | -400.20% |
| Q3 2023 Q2Q % growth | -0.07 77.42% | -0.12 | 0.05 | 42.81% |
| Q2 2023 Q2Q % growth | -0.21 -10.53% | -0.16 | -0.05 | -31.55% |
| Q1 2023 Q2Q % growth | -0.23 -64.29% | -0.21 | -0.02 | -7.48% |
| Q4 2022 Q2Q % growth | -0.26 -44.44% | -0.27 | 0.01 | 3.75% |
| Q3 2022 Q2Q % growth | -0.31 -93.75% | -0.19 | -0.12 | -67.29% |
| Q2 2022 Q2Q % growth | -0.19 -26.67% | -0.14 | -0.05 | -36.30% |
| Q1 2022 Q2Q % growth | -0.14 22.22% | -0.14 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.18 -38.46% | 0.76 | -0.94 | -123.61% |
| Q3 2021 Q2Q % growth | -0.16 33.33% | -0.17 | 0.01 | 7.73% |
| Q2 2021 Q2Q % growth | -0.15 28.57% | -0.19 | 0.04 | 21.78% |
| Q1 2021 Q2Q % growth | -0.18 5.26% | -0.13 | -0.05 | -35.75% |
| Q4 2020 Q2Q % growth | -0.13 27.78% | -0.19 | 0.06 | 32.92% |
| Q3 2020 Q2Q % growth | -0.24 -166.67% | -0.19 | -0.05 | -23.84% |
| Q2 2020 Q2Q % growth | -0.21 12.50% | -0.18 | -0.03 | -16.53% |
| Q1 2020 Q2Q % growth | -0.19 -46.15% | -0.19 | 0.00 | 0.21% |
| Q4 2019 Q2Q % growth | -0.18 | -0.13 | -0.05 | -35.75% |
| Q3 2019 Q2Q % growth | -0.09 | -0.20 | 0.11 | 55.88% |
| Q2 2019 Q2Q % growth | -0.24 | -0.14 | -0.10 | -72.16% |
| Q1 2019 Q2Q % growth | -0.13 | -0.16 | 0.03 | 16.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 6.974M 12.77% | 9.162M | -2.188M | -23.88% |
| Q2 2024 Q2Q % growth | 7.262M 118.41% | 11.269M | -4.007M | -35.56% |
| Q1 2024 Q2Q % growth | 25.377M 1,413.24% | 19.254M | 6.123M | 31.80% |
| Q4 2023 Q2Q % growth | 9.735M 532.14% | 8.843M | 892K | 10.09% |
| Q3 2023 Q2Q % growth | 6.184M | 5.443M | 741K | 13.61% |
| Q2 2023 Q2Q % growth | 3.325M | 3.81M | -485K | -12.73% |
| Q1 2023 Q2Q % growth | 1.677M | 1.884M | -207K | -10.99% |
| Q4 2022 Q2Q % growth | 1.54M | 759.727K | 780.273K | 102.70% |
| Q4 2021 Q2Q % growth | -100.00% | 34M | -34M | -100.00% |
| Q3 2020 Q2Q % growth | 484.5K | -484.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4884.98% | 4884.98% | 540% | 51.86% |
| Revenue | 120.38% | 120.38% | 0% | 24.91% |